脳性麻痺のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Cerebral Palsy Market Insights and Forecast to 2028

Global Cerebral Palsy Market Insights and Forecast to 2028「脳性麻痺のグローバル市場インサイト・予測(~2028年)」(市場規模、市場予測)調査レポートです。• レポートコード:QY2203B13155
• 出版社/出版日:QYResearch / 2022年3月18日
• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥715,400 (USD4,900)▷ お問い合わせ
  Multi User¥1,073,100 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,430,800 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の脳性麻痺の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脳性麻痺の世界市場のxxx%を占める「UMC-11910」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の脳性麻痺の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの脳性麻痺市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの脳性麻痺市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

脳性麻痺のグローバル主要メーカーには、Allergan Plc、Cell Cure Neurosciences, Ltd.、Cellular Biomedicine Group, Inc.、CHA Bio & Diostech Co., Ltd.、Neuralstem, Inc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

脳性麻痺市場は、種類と用途によって区分されます。世界の脳性麻痺市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
UMC-11910、サイト-012、ナビキシモルス、その他

【用途別セグメント】
病院、診療所、研究センター

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 脳性麻痺製品概要
- 種類別市場(UMC-11910、サイト-012、ナビキシモルス、その他)
- 用途別市場(病院、診療所、研究センター)
- 調査の目的
・エグゼクティブサマリー
- 世界の脳性麻痺販売量予測2017-2028
- 世界の脳性麻痺売上予測2017-2028
- 脳性麻痺の地域別販売量
- 脳性麻痺の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別脳性麻痺販売量
- 主要メーカー別脳性麻痺売上
- 主要メーカー別脳性麻痺価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(UMC-11910、サイト-012、ナビキシモルス、その他)
- 脳性麻痺の種類別販売量
- 脳性麻痺の種類別売上
- 脳性麻痺の種類別価格
・用途別市場規模(病院、診療所、研究センター)
- 脳性麻痺の用途別販売量
- 脳性麻痺の用途別売上
- 脳性麻痺の用途別価格
・北米市場
- 北米の脳性麻痺市場規模(種類別、用途別)
- 主要国別の脳性麻痺市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの脳性麻痺市場規模(種類別、用途別)
- 主要国別の脳性麻痺市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の脳性麻痺市場規模(種類別、用途別)
- 主要国別の脳性麻痺市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の脳性麻痺市場規模(種類別、用途別)
- 主要国別の脳性麻痺市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの脳性麻痺市場規模(種類別、用途別)
- 主要国別の脳性麻痺市場規模(トルコ、サウジアラビア)
・企業情報
Allergan Plc、Cell Cure Neurosciences, Ltd.、Cellular Biomedicine Group, Inc.、CHA Bio & Diostech Co., Ltd.、Neuralstem, Inc.
・産業チェーン及び販売チャネル分析
- 脳性麻痺の産業チェーン分析
- 脳性麻痺の原材料
- 脳性麻痺の生産プロセス
- 脳性麻痺の販売及びマーケティング
- 脳性麻痺の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 脳性麻痺の産業動向
- 脳性麻痺のマーケットドライバー
- 脳性麻痺の課題
- 脳性麻痺の阻害要因
・主な調査結果

Market Analysis and Insights: Global Cerebral Palsy Market
Due to the COVID-19 pandemic, the global Cerebral Palsy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, UMC-11910 accounting for % of the Cerebral Palsy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Cerebral Palsy market size is valued at US$ million in 2021, while the US and Europe Cerebral Palsy are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cerebral Palsy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Cerebral Palsy include Allergan Plc, Cell Cure Neurosciences, Ltd., Cellular Biomedicine Group, Inc., CHA Bio & Diostech Co., Ltd. and Neuralstem, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Cerebral Palsy Scope and Segment
Cerebral Palsy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cerebral Palsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
UMC-11910
Cyto-012
Nabiximols
Others
Segment by Application
Hospital
Clinic
Research Center
By Company
Allergan Plc
Cell Cure Neurosciences, Ltd.
Cellular Biomedicine Group, Inc.
CHA Bio & Diostech Co., Ltd.
Neuralstem, Inc.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

1 Study Coverage
1.1 Cerebral Palsy Product Introduction
1.2 Market by Type
1.2.1 Global Cerebral Palsy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 UMC-11910
1.2.3 Cyto-012
1.2.4 Nabiximols
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cerebral Palsy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cerebral Palsy Sales Estimates and Forecasts 2017-2028
2.2 Global Cerebral Palsy Revenue Estimates and Forecasts 2017-2028
2.3 Global Cerebral Palsy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cerebral Palsy Sales by Region
2.4.1 Global Cerebral Palsy Sales by Region (2017-2022)
2.4.2 Global Sales Cerebral Palsy by Region (2023-2028)
2.5 Global Cerebral Palsy Revenue by Region
2.5.1 Global Cerebral Palsy Revenue by Region (2017-2022)
2.5.2 Global Cerebral Palsy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cerebral Palsy Sales by Manufacturers
3.1.1 Global Top Cerebral Palsy Manufacturers by Sales (2017-2022)
3.1.2 Global Cerebral Palsy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cerebral Palsy in 2021
3.2 Global Cerebral Palsy Revenue by Manufacturers
3.2.1 Global Cerebral Palsy Revenue by Manufacturers (2017-2022)
3.2.2 Global Cerebral Palsy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cerebral Palsy Revenue in 2021
3.3 Global Cerebral Palsy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cerebral Palsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cerebral Palsy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cerebral Palsy Sales by Type
4.1.1 Global Cerebral Palsy Historical Sales by Type (2017-2022)
4.1.2 Global Cerebral Palsy Forecasted Sales by Type (2023-2028)
4.1.3 Global Cerebral Palsy Sales Market Share by Type (2017-2028)
4.2 Global Cerebral Palsy Revenue by Type
4.2.1 Global Cerebral Palsy Historical Revenue by Type (2017-2022)
4.2.2 Global Cerebral Palsy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cerebral Palsy Revenue Market Share by Type (2017-2028)
4.3 Global Cerebral Palsy Price by Type
4.3.1 Global Cerebral Palsy Price by Type (2017-2022)
4.3.2 Global Cerebral Palsy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cerebral Palsy Sales by Application
5.1.1 Global Cerebral Palsy Historical Sales by Application (2017-2022)
5.1.2 Global Cerebral Palsy Forecasted Sales by Application (2023-2028)
5.1.3 Global Cerebral Palsy Sales Market Share by Application (2017-2028)
5.2 Global Cerebral Palsy Revenue by Application
5.2.1 Global Cerebral Palsy Historical Revenue by Application (2017-2022)
5.2.2 Global Cerebral Palsy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cerebral Palsy Revenue Market Share by Application (2017-2028)
5.3 Global Cerebral Palsy Price by Application
5.3.1 Global Cerebral Palsy Price by Application (2017-2022)
5.3.2 Global Cerebral Palsy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cerebral Palsy Market Size by Type
6.1.1 North America Cerebral Palsy Sales by Type (2017-2028)
6.1.2 North America Cerebral Palsy Revenue by Type (2017-2028)
6.2 North America Cerebral Palsy Market Size by Application
6.2.1 North America Cerebral Palsy Sales by Application (2017-2028)
6.2.2 North America Cerebral Palsy Revenue by Application (2017-2028)
6.3 North America Cerebral Palsy Market Size by Country
6.3.1 North America Cerebral Palsy Sales by Country (2017-2028)
6.3.2 North America Cerebral Palsy Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cerebral Palsy Market Size by Type
7.1.1 Europe Cerebral Palsy Sales by Type (2017-2028)
7.1.2 Europe Cerebral Palsy Revenue by Type (2017-2028)
7.2 Europe Cerebral Palsy Market Size by Application
7.2.1 Europe Cerebral Palsy Sales by Application (2017-2028)
7.2.2 Europe Cerebral Palsy Revenue by Application (2017-2028)
7.3 Europe Cerebral Palsy Market Size by Country
7.3.1 Europe Cerebral Palsy Sales by Country (2017-2028)
7.3.2 Europe Cerebral Palsy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cerebral Palsy Market Size by Type
8.1.1 Asia Pacific Cerebral Palsy Sales by Type (2017-2028)
8.1.2 Asia Pacific Cerebral Palsy Revenue by Type (2017-2028)
8.2 Asia Pacific Cerebral Palsy Market Size by Application
8.2.1 Asia Pacific Cerebral Palsy Sales by Application (2017-2028)
8.2.2 Asia Pacific Cerebral Palsy Revenue by Application (2017-2028)
8.3 Asia Pacific Cerebral Palsy Market Size by Region
8.3.1 Asia Pacific Cerebral Palsy Sales by Region (2017-2028)
8.3.2 Asia Pacific Cerebral Palsy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Cerebral Palsy Market Size by Type
9.1.1 Latin America Cerebral Palsy Sales by Type (2017-2028)
9.1.2 Latin America Cerebral Palsy Revenue by Type (2017-2028)
9.2 Latin America Cerebral Palsy Market Size by Application
9.2.1 Latin America Cerebral Palsy Sales by Application (2017-2028)
9.2.2 Latin America Cerebral Palsy Revenue by Application (2017-2028)
9.3 Latin America Cerebral Palsy Market Size by Country
9.3.1 Latin America Cerebral Palsy Sales by Country (2017-2028)
9.3.2 Latin America Cerebral Palsy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cerebral Palsy Market Size by Type
10.1.1 Middle East and Africa Cerebral Palsy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cerebral Palsy Revenue by Type (2017-2028)
10.2 Middle East and Africa Cerebral Palsy Market Size by Application
10.2.1 Middle East and Africa Cerebral Palsy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cerebral Palsy Revenue by Application (2017-2028)
10.3 Middle East and Africa Cerebral Palsy Market Size by Country
10.3.1 Middle East and Africa Cerebral Palsy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cerebral Palsy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Corporation Information
11.1.2 Allergan Plc Overview
11.1.3 Allergan Plc Cerebral Palsy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Plc Cerebral Palsy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Plc Recent Developments
11.2 Cell Cure Neurosciences, Ltd.
11.2.1 Cell Cure Neurosciences, Ltd. Corporation Information
11.2.2 Cell Cure Neurosciences, Ltd. Overview
11.2.3 Cell Cure Neurosciences, Ltd. Cerebral Palsy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cell Cure Neurosciences, Ltd. Cerebral Palsy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cell Cure Neurosciences, Ltd. Recent Developments
11.3 Cellular Biomedicine Group, Inc.
11.3.1 Cellular Biomedicine Group, Inc. Corporation Information
11.3.2 Cellular Biomedicine Group, Inc. Overview
11.3.3 Cellular Biomedicine Group, Inc. Cerebral Palsy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cellular Biomedicine Group, Inc. Cerebral Palsy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cellular Biomedicine Group, Inc. Recent Developments
11.4 CHA Bio & Diostech Co., Ltd.
11.4.1 CHA Bio & Diostech Co., Ltd. Corporation Information
11.4.2 CHA Bio & Diostech Co., Ltd. Overview
11.4.3 CHA Bio & Diostech Co., Ltd. Cerebral Palsy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 CHA Bio & Diostech Co., Ltd. Cerebral Palsy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CHA Bio & Diostech Co., Ltd. Recent Developments
11.5 Neuralstem, Inc.
11.5.1 Neuralstem, Inc. Corporation Information
11.5.2 Neuralstem, Inc. Overview
11.5.3 Neuralstem, Inc. Cerebral Palsy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Neuralstem, Inc. Cerebral Palsy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Neuralstem, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cerebral Palsy Industry Chain Analysis
12.2 Cerebral Palsy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cerebral Palsy Production Mode & Process
12.4 Cerebral Palsy Sales and Marketing
12.4.1 Cerebral Palsy Sales Channels
12.4.2 Cerebral Palsy Distributors
12.5 Cerebral Palsy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cerebral Palsy Industry Trends
13.2 Cerebral Palsy Market Drivers
13.3 Cerebral Palsy Market Challenges
13.4 Cerebral Palsy Market Restraints
14 Key Findings in The Global Cerebral Palsy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Cerebral Palsy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of UMC-11910
Table 3. Major Manufacturers of Cyto-012
Table 4. Major Manufacturers of Nabiximols
Table 5. Major Manufacturers of Others
Table 6. Global Cerebral Palsy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Cerebral Palsy Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Cerebral Palsy Sales by Region (2017-2022) & (K Pcs)
Table 9. Global Cerebral Palsy Sales Market Share by Region (2017-2022)
Table 10. Global Cerebral Palsy Sales by Region (2023-2028) & (K Pcs)
Table 11. Global Cerebral Palsy Sales Market Share by Region (2023-2028)
Table 12. Global Cerebral Palsy Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Cerebral Palsy Revenue Market Share by Region (2017-2022)
Table 14. Global Cerebral Palsy Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Cerebral Palsy Revenue Market Share by Region (2023-2028)
Table 16. Global Cerebral Palsy Sales by Manufacturers (2017-2022) & (K Pcs)
Table 17. Global Cerebral Palsy Sales Share by Manufacturers (2017-2022)
Table 18. Global Cerebral Palsy Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Cerebral Palsy Revenue Share by Manufacturers (2017-2022)
Table 20. Cerebral Palsy Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 21. Global Cerebral Palsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Cerebral Palsy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebral Palsy as of 2021)
Table 23. Cerebral Palsy Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Cerebral Palsy Product Offered
Table 25. Date of Manufacturers Enter into Cerebral Palsy Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cerebral Palsy Sales by Type (2017-2022) & (K Pcs)
Table 28. Global Cerebral Palsy Sales by Type (2023-2028) & (K Pcs)
Table 29. Global Cerebral Palsy Sales Share by Type (2017-2022)
Table 30. Global Cerebral Palsy Sales Share by Type (2023-2028)
Table 31. Global Cerebral Palsy Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Cerebral Palsy Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Cerebral Palsy Revenue Share by Type (2017-2022)
Table 34. Global Cerebral Palsy Revenue Share by Type (2023-2028)
Table 35. Cerebral Palsy Price by Type (2017-2022) & (USD/Pcs)
Table 36. Global Cerebral Palsy Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 37. Global Cerebral Palsy Sales by Application (2017-2022) & (K Pcs)
Table 38. Global Cerebral Palsy Sales by Application (2023-2028) & (K Pcs)
Table 39. Global Cerebral Palsy Sales Share by Application (2017-2022)
Table 40. Global Cerebral Palsy Sales Share by Application (2023-2028)
Table 41. Global Cerebral Palsy Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Cerebral Palsy Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Cerebral Palsy Revenue Share by Application (2017-2022)
Table 44. Global Cerebral Palsy Revenue Share by Application (2023-2028)
Table 45. Cerebral Palsy Price by Application (2017-2022) & (USD/Pcs)
Table 46. Global Cerebral Palsy Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 47. North America Cerebral Palsy Sales by Type (2017-2022) & (K Pcs)
Table 48. North America Cerebral Palsy Sales by Type (2023-2028) & (K Pcs)
Table 49. North America Cerebral Palsy Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Cerebral Palsy Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Cerebral Palsy Sales by Application (2017-2022) & (K Pcs)
Table 52. North America Cerebral Palsy Sales by Application (2023-2028) & (K Pcs)
Table 53. North America Cerebral Palsy Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Cerebral Palsy Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Cerebral Palsy Sales by Country (2017-2022) & (K Pcs)
Table 56. North America Cerebral Palsy Sales by Country (2023-2028) & (K Pcs)
Table 57. North America Cerebral Palsy Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Cerebral Palsy Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Cerebral Palsy Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Cerebral Palsy Sales by Type (2023-2028) & (K Pcs)
Table 61. Europe Cerebral Palsy Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Cerebral Palsy Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Cerebral Palsy Sales by Application (2017-2022) & (K Pcs)
Table 64. Europe Cerebral Palsy Sales by Application (2023-2028) & (K Pcs)
Table 65. Europe Cerebral Palsy Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Cerebral Palsy Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Cerebral Palsy Sales by Country (2017-2022) & (K Pcs)
Table 68. Europe Cerebral Palsy Sales by Country (2023-2028) & (K Pcs)
Table 69. Europe Cerebral Palsy Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Cerebral Palsy Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Cerebral Palsy Sales by Type (2017-2022) & (K Pcs)
Table 72. Asia Pacific Cerebral Palsy Sales by Type (2023-2028) & (K Pcs)
Table 73. Asia Pacific Cerebral Palsy Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Cerebral Palsy Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Cerebral Palsy Sales by Application (2017-2022) & (K Pcs)
Table 76. Asia Pacific Cerebral Palsy Sales by Application (2023-2028) & (K Pcs)
Table 77. Asia Pacific Cerebral Palsy Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Cerebral Palsy Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Cerebral Palsy Sales by Region (2017-2022) & (K Pcs)
Table 80. Asia Pacific Cerebral Palsy Sales by Region (2023-2028) & (K Pcs)
Table 81. Asia Pacific Cerebral Palsy Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Cerebral Palsy Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Cerebral Palsy Sales by Type (2017-2022) & (K Pcs)
Table 84. Latin America Cerebral Palsy Sales by Type (2023-2028) & (K Pcs)
Table 85. Latin America Cerebral Palsy Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Cerebral Palsy Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Cerebral Palsy Sales by Application (2017-2022) & (K Pcs)
Table 88. Latin America Cerebral Palsy Sales by Application (2023-2028) & (K Pcs)
Table 89. Latin America Cerebral Palsy Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Cerebral Palsy Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Cerebral Palsy Sales by Country (2017-2022) & (K Pcs)
Table 92. Latin America Cerebral Palsy Sales by Country (2023-2028) & (K Pcs)
Table 93. Latin America Cerebral Palsy Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Cerebral Palsy Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Cerebral Palsy Sales by Type (2017-2022) & (K Pcs)
Table 96. Middle East and Africa Cerebral Palsy Sales by Type (2023-2028) & (K Pcs)
Table 97. Middle East and Africa Cerebral Palsy Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Cerebral Palsy Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Cerebral Palsy Sales by Application (2017-2022) & (K Pcs)
Table 100. Middle East and Africa Cerebral Palsy Sales by Application (2023-2028) & (K Pcs)
Table 101. Middle East and Africa Cerebral Palsy Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Cerebral Palsy Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Cerebral Palsy Sales by Country (2017-2022) & (K Pcs)
Table 104. Middle East and Africa Cerebral Palsy Sales by Country (2023-2028) & (K Pcs)
Table 105. Middle East and Africa Cerebral Palsy Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Cerebral Palsy Revenue by Country (2023-2028) & (US$ Million)
Table 107. Allergan Plc Corporation Information
Table 108. Allergan Plc Description and Major Businesses
Table 109. Allergan Plc Cerebral Palsy Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Allergan Plc Cerebral Palsy Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Allergan Plc Recent Developments
Table 112. Cell Cure Neurosciences, Ltd. Corporation Information
Table 113. Cell Cure Neurosciences, Ltd. Description and Major Businesses
Table 114. Cell Cure Neurosciences, Ltd. Cerebral Palsy Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Cell Cure Neurosciences, Ltd. Cerebral Palsy Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Cell Cure Neurosciences, Ltd. Recent Developments
Table 117. Cellular Biomedicine Group, Inc. Corporation Information
Table 118. Cellular Biomedicine Group, Inc. Description and Major Businesses
Table 119. Cellular Biomedicine Group, Inc. Cerebral Palsy Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Cellular Biomedicine Group, Inc. Cerebral Palsy Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Cellular Biomedicine Group, Inc. Recent Developments
Table 122. CHA Bio & Diostech Co., Ltd. Corporation Information
Table 123. CHA Bio & Diostech Co., Ltd. Description and Major Businesses
Table 124. CHA Bio & Diostech Co., Ltd. Cerebral Palsy Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. CHA Bio & Diostech Co., Ltd. Cerebral Palsy Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. CHA Bio & Diostech Co., Ltd. Recent Developments
Table 127. Neuralstem, Inc. Corporation Information
Table 128. Neuralstem, Inc. Description and Major Businesses
Table 129. Neuralstem, Inc. Cerebral Palsy Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. Neuralstem, Inc. Cerebral Palsy Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Neuralstem, Inc. Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Cerebral Palsy Distributors List
Table 135. Cerebral Palsy Customers List
Table 136. Cerebral Palsy Market Trends
Table 137. Cerebral Palsy Market Drivers
Table 138. Cerebral Palsy Market Challenges
Table 139. Cerebral Palsy Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Cerebral Palsy Product Picture
Figure 3. Global Cerebral Palsy Market Share by Type in 2021 & 2028
Figure 3. UMC-11910 Product Picture
Figure 4. Cyto-012 Product Picture
Figure 5. Nabiximols Product Picture
Figure 6. Others Product Picture
Figure 7. Global Cerebral Palsy Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Research Center
Figure 11. Cerebral Palsy Report Years Considered
Figure 12. Global Cerebral Palsy Sales 2017-2028 (K Pcs)
Figure 13. Global Cerebral Palsy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Cerebral Palsy Revenue 2017-2028 (US$ Million)
Figure 15. Global Cerebral Palsy Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Cerebral Palsy Sales Market Share by Region (2017-2022)
Figure 17. Global Cerebral Palsy Sales Market Share by Region (2023-2028)
Figure 18. North America Cerebral Palsy Sales YoY (2017-2028) & (K Pcs)
Figure 19. North America Cerebral Palsy Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Cerebral Palsy Sales YoY (2017-2028) & (K Pcs)
Figure 21. Europe Cerebral Palsy Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Cerebral Palsy Sales YoY (2017-2028) & (K Pcs)
Figure 23. Asia-Pacific Cerebral Palsy Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Cerebral Palsy Sales YoY (2017-2028) & (K Pcs)
Figure 25. Latin America Cerebral Palsy Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Cerebral Palsy Sales YoY (2017-2028) & (K Pcs)
Figure 27. Middle East & Africa Cerebral Palsy Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Cerebral Palsy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Cerebral Palsy in the World: Market Share by Cerebral Palsy Revenue in 2021
Figure 30. Global Cerebral Palsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Cerebral Palsy Sales Market Share by Type (2017-2028)
Figure 32. Global Cerebral Palsy Revenue Market Share by Type (2017-2028)
Figure 33. Global Cerebral Palsy Sales Market Share by Application (2017-2028)
Figure 34. Global Cerebral Palsy Revenue Market Share by Application (2017-2028)
Figure 35. North America Cerebral Palsy Sales Market Share by Type (2017-2028)
Figure 36. North America Cerebral Palsy Revenue Market Share by Type (2017-2028)
Figure 37. North America Cerebral Palsy Sales Market Share by Application (2017-2028)
Figure 38. North America Cerebral Palsy Revenue Market Share by Application (2017-2028)
Figure 39. North America Cerebral Palsy Sales Share by Country (2017-2028)
Figure 40. North America Cerebral Palsy Revenue Share by Country (2017-2028)
Figure 41. U.S. Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Cerebral Palsy Sales Market Share by Type (2017-2028)
Figure 44. Europe Cerebral Palsy Revenue Market Share by Type (2017-2028)
Figure 45. Europe Cerebral Palsy Sales Market Share by Application (2017-2028)
Figure 46. Europe Cerebral Palsy Revenue Market Share by Application (2017-2028)
Figure 47. Europe Cerebral Palsy Sales Share by Country (2017-2028)
Figure 48. Europe Cerebral Palsy Revenue Share by Country (2017-2028)
Figure 49. Germany Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 50. France Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Cerebral Palsy Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Cerebral Palsy Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Cerebral Palsy Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Cerebral Palsy Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Cerebral Palsy Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Cerebral Palsy Revenue Share by Region (2017-2028)
Figure 60. China Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 63. India Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Cerebral Palsy Sales Market Share by Type (2017-2028)
Figure 71. Latin America Cerebral Palsy Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Cerebral Palsy Sales Market Share by Application (2017-2028)
Figure 73. Latin America Cerebral Palsy Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Cerebral Palsy Sales Share by Country (2017-2028)
Figure 75. Latin America Cerebral Palsy Revenue Share by Country (2017-2028)
Figure 76. Mexico Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Cerebral Palsy Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Cerebral Palsy Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Cerebral Palsy Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Cerebral Palsy Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Cerebral Palsy Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Cerebral Palsy Revenue Share by Country (2017-2028)
Figure 85. Turkey Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Cerebral Palsy Revenue (2017-2028) & (US$ Million)
Figure 88. Cerebral Palsy Value Chain
Figure 89. Cerebral Palsy Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed



• 英文レポート名:Global Cerebral Palsy Market Insights and Forecast to 2028
• 日本語訳:脳性麻痺のグローバル市場インサイト・予測(~2028年)
• レポートコード:QY2203B13155お問い合わせ(見積依頼・ご注文・質問)